Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Drug Targeting towards Fighting Pathogen Bacteria"
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Targeting and Design".
Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 5436
Special Issue Editor
Interests: nanomaterials; antimicrobial polymers; antimicrobial peptides; anticancer polymers; bacterial biofilms; biophysics; confocal and two-photon microscopy
Special Issue Information
One of the major public health concerns of the 21st century is the continuous emergence of antibiotic-resistant strains, which cause a serious threat to the efficient prevention and treatment of bacterial-related infections.
Antibiotic resistance can be considered an inevitable consequence of the rambunctious and unregulated use of antibiotics, which remains a major factor facilitating the emergence of antibiotics resistance worldwide.
Several fields of medicine depend on the availability of antibiotic drugs; for instance, the immunosuppression induced by cancer therapy and long-term vascular catheter placement make cancer patients susceptible to bacterial infections often caused by resistant organisms, such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Thus, to avoid secondary infections, cancer patients are routinely given antibiotics, which cause many side effects, including antimicrobial resistance.
Conventional antibiotics have many disadvantages, such as the development of resistance and, in some cases, a low therapeutic index. Thus, more efficient and effective compounds are urgently required.
This Special Issue aims to identify novel strategies and/or compounds that can help improve the success of bacterial treatment.
In this Special Issue, original research articles and reviews are welcome. Research areas may include (but are not limited to) the following:
- Antimicrobial polymers;
- Antimicrobial peptides and peptidomimetics;
- Use of natural products;
- Combinations of antimicrobial agents effect;
- Inhibitors of virulence factors;
- Use of nanoparticles;
- Drug delivery systems;
- Topical antimicrobial treatment;
- Phage therapy;
This Special Issue welcomes different types of submissions, such as original research papers, short communications, reviews, case reports, and opinion papers.
I look forward to receiving your contributions.
Dr. Sandra N. Pinto
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- antimicrobial compounds
- antibiotic resistance
- bacterial infections
- antimicrobial strategies